MCQ: Acute Severe Asthma | Management

Correct Answer

C. Endotracheal intubation and mechanical ventilation

Explanation: Acute severe Asthma 

This 12-year-old boy has life-threatening acute severe asthma with impending respiratory failure despite intensive medical therapy.

He has already received appropriate aggressive treatment, including repeated inhaled bronchodilators, ipratropium, systemic corticosteroids, intravenous magnesium sulfate, and supplemental oxygen. Despite this, he remains exhausted and hypoxemic and has developed several features of impending respiratory failure.

The most concerning findings are:

• Drowsiness with reduced responsiveness
• Markedly reduced bilateral air entry (“silent chest”)
• Persistent hypoxemia despite high-flow oxygen
• PaCO₂ of 58 mmHg
• Respiratory acidosis with pH 7.28
• Clinical exhaustion despite maximal initial therapy

Together, these findings indicate progressive ventilatory failure and a high risk of respiratory arrest.

Why is the PaCO₂ particularly important?

In an acute severe asthma attack, airway obstruction initially causes marked tachypnea and increased alveolar ventilation. As a result, children commonly have a low PaCO₂ during the early stages of a severe exacerbation.

Therefore, a normalizing, rising, or elevated PaCO₂ in a child who remains severely obstructed is an ominous finding. It suggests that the child is becoming unable to maintain adequate alveolar ventilation because of increasing respiratory muscle fatigue. Persistent or increasing hypercapnia, exhaustion, and depressed mental status strongly suggest the need for ventilatory support

In this case, the PaCO₂ of 58 mmHg together with a pH of 7.28 demonstrates hypercapnic respiratory failure with respiratory acidosis.

The ABG should therefore not be interpreted simply as “asthma with hypercapnia”; it represents failure of ventilation in a child who is clinically deteriorating.

Why is the “silent chest” dangerous?

A silent chest does not mean that the bronchospasm has improved.

In severe asthma, profound airflow obstruction can become so severe that very little air moves through the airways. Consequently, wheezing may become faint or disappear altogether.

Thus:

Less wheezing + worsening clinical condition = potentially worse airflow obstruction, not improvement.

A silent chest, especially when associated with drowsiness, exhaustion and hypercapnia, is a major warning sign of impending respiratory arrest.

Why is drowsiness an indication for airway protection?

Drowsiness in this setting suggests significant respiratory compromise and potentially inadequate cerebral oxygen delivery and/or progressive hypercapnia.

More importantly, a drowsy child may be unable to:

• Maintain airway protection
• Generate adequate respiratory effort
• Cooperate with non-invasive ventilation
• Clear respiratory secretions effectively

Therefore, continuing to rely on spontaneous ventilation is unsafe.

Why is intubation the appropriate next step?

This child has progressed from severe bronchospasm to impending respiratory failure despite intensive medical treatment.

He requires:

1. Endotracheal intubation to secure the airway.
2. Mechanical ventilation to provide adequate alveolar ventilation and oxygenation.
3. Continued treatment of the underlying bronchospasm with appropriate bronchodilator and corticosteroid therapy.

Intubation in severe asthma is technically challenging because airway resistance is extremely high and positive-pressure ventilation can cause dynamic hyperinflation and auto-PEEP. Ventilator management therefore generally emphasizes adequate expiratory time and avoidance of excessive minute ventilation rather than attempting to normalize PaCO₂ immediately.

The objective is to maintain adequate oxygenation and ventilation while allowing sufficient time for expiration and reducing air trapping.

Why the other options are incorrect

A. Repeat intravenous magnesium sulfate

Intravenous magnesium sulfate is an accepted adjunct in severe or critical asthma, particularly when there is inadequate response to initial intensive bronchodilator therapy.

However, this child has already received magnesium sulfate and has now developed clinical and biochemical evidence of respiratory failure.

Repeating magnesium should not delay definitive airway and ventilatory support.

Exam clue: Once severe asthma has progressed to altered consciousness, a silent chest, hypoxemia and hypercapnic respiratory acidosis, think respiratory support rather than another adjunctive bronchodilator strategy.

B. Start aminophylline infusion

Intravenous aminophylline/theophylline is not routinely recommended for acute severe asthma in children because its additional clinical benefit is limited and it has a relatively narrow therapeutic range.

Adverse effects can include:

• Nausea and vomiting
• Tachycardia
• Arrhythmias
• Tremor
• Seizures

Most importantly, aminophylline should never delay definitive ventilatory support in a child who is already developing respiratory failure.

C. Endotracheal intubation and mechanical ventilation

Correct.

This child has multiple indications for invasive ventilatory support:

• Altered mental status
• Severe exhaustion
• Silent chest
• Persistent hypoxemia despite oxygen
• Hypercapnia
• Respiratory acidosis
• Failure to respond to intensive medical treatment

The combination of deteriorating consciousness + silent chest + rising PaCO₂ is particularly concerning.

D. Increase the frequency of salbutamol nebulization

Inhaled short-acting β₂-agonists remain the cornerstone of acute asthma treatment, and continuous or frequent nebulized salbutamol may be used in severe exacerbations.

However, this child has already received repeated nebulized salbutamol and has progressed to respiratory failure.

Increasing the frequency of nebulization alone cannot correct the underlying ventilatory failure and should not postpone intubation.

Bronchodilator therapy should continue as part of the overall management while respiratory support is established.

E. Start non-invasive ventilation

Non-invasive ventilation may be considered in carefully selected, cooperative patients with severe asthma and respiratory muscle fatigue.

It is inappropriate in this case because the child is drowsy, poorly responsive and approaching respiratory arrest.

A patient receiving NIV must be able to protect the airway and cooperate with the treatment. In a child with deteriorating consciousness and severe hypercapnic respiratory failure, NIV can delay definitive airway management and may increase the risk of aspiration.

Therefore, invasive ventilation is preferred.

High-Yield Exam Point

In a child with severe asthma, the following combination should immediately raise concern for impending respiratory failure:

Drowsiness + silent chest + persistent hypoxemia + rising/elevated PaCO₂ + respiratory acidosis

A particularly important exam principle is:

In severe asthma, a rising PaCO₂ is a warning sign of worsening ventilatory failure.

A child who is becoming drowsy and developing hypercapnic respiratory acidosis despite aggressive treatment requires urgent airway and ventilatory support, rather than simply escalating bronchodilator therapy.

Clinical Pearl

Wheeze is produced by airflow. In extremely severe airway obstruction, airflow may become so limited that wheezing disappears. Therefore, a “silent chest” in a deteriorating child with asthma is a sign of severe airflow limitation—not clinical improvement.

You can also practice another MCQ on Spirometry pattern in Asthma. 

References

1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda (MD): National Heart, Lung, and Blood Institute; 2007.
2. Goodfellow LT, Abu-Sultaneh S, et al. AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma. Respir Care. 2025.